IM Cannabis Corp. current report, Q4 FY2022

IM Cannabis Corp. Form 6-K Summary

Business context and reporting period

IM Cannabis Corp., an Israel-based foreign private issuer, filed this Form 6-K for December 2022. The filing is dated December 12, 2022 and identifies the company’s principal executive offices in Kibbutz Glil Yam, Israel.

The filing furnishes Exhibit 99.1, titled “Form 10—Notice of Proposed Significant Transaction,” dated December 12, 2022. The text of that exhibit is not included in the provided filing content.

Financial metrics

The provided filing text does not report revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material changes versus the prior comparable period

The filing text does not provide comparative-period information or describe specific changes in the company’s financial or operating performance.

Guidance, outlook, risks, and unusual items

The filing references a proposed significant transaction through Exhibit 99.1, but the transaction’s terms, parties, timing, financial effects, conditions, risks, and contingencies are not provided in the available text.

Exhibit 99.1 is incorporated by reference into the company’s Registration Statement on Form F-10, File No. 333-254255, as amended or supplemented.

Investor verification points

  • Obtain and review the full text of Exhibit 99.1 to determine the nature and terms of the proposed significant transaction.
  • Verify any transaction consideration, financing arrangements, closing conditions, approvals, dilution, and expected effects on the company’s financial position.
  • Review subsequent filings for completion, modification, termination, or additional risks related to the proposed transaction.
  • Use the company’s financial statements or other filings to assess revenue, profitability, cash flow, debt, and liquidity, as these figures are not included here.